Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3025 of 3546 entries
View as:

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Phase: N/A Priority: Normal
NCT ID: NCT05975840 Org: User:
Start: 08/03/23 End: 05/21/24 Due: 05/21/25

Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study

Phase: N/A Priority: Normal
NCT ID: NCT04052620 Org: User:
Start: 10/24/19 End: 11/12/20 Due: 11/12/21

A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01610492 Org: User:
Start: 07/01/12 End: 09/14/16 Due: 09/14/17

Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

Phase: N/A Priority: Normal
NCT ID: NCT01277705 Org: User:
Start: 01/31/02 End: 04/30/02 Due: 04/30/03

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

Phase: N/A Priority: Normal
NCT ID: NCT00473668 Org: User:
Start: 06/01/07 End: 01/30/08 Due: 01/30/09

Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01536561 Org: User:
Start: 04/24/90 End: 10/16/09 Due: 10/16/10

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Phase: N/A Priority: Normal
NCT ID: NCT00875485 Org: User:
Start: 05/01/09 End: 07/01/14 Due: 07/01/15

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT02218697 Org: User:
Start: 10/01/14 End: 05/04/15 Due: 05/04/16

Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00911196 Org: User:
Start: 11/30/08 End: 03/31/09 Due: 03/31/10

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers

Phase: N/A Priority: Normal
NCT ID: NCT01762774 Org: User:
Start: 01/16/13 End: 05/01/14 Due: 05/01/15

To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00426816 Org: User:
Start: 12/31/06 End: 05/31/07 Due: 05/31/08

HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab

Phase: N/A Priority: Normal
NCT ID: NCT00349349 Org: User:
Start: 06/30/06 End: 06/30/12 Due: 06/30/13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02177734 Org: User:
Start: 03/31/16 End: 05/31/17 Due: 05/31/18

Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT00257582 Org: User:
Start: 08/31/05 End: - Due: -

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02858492 Org: User:
Start: 10/17/16 End: 10/22/18 Due: 10/22/19

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Phase: N/A Priority: Normal
NCT ID: NCT00929331 Org: User:
Start: 07/11/09 End: 08/01/09 Due: 08/01/10

Cost of Illness Associated With Influenza in the UK

Phase: N/A Priority: Normal
NCT ID: NCT01521416 Org: User:
Start: 06/30/11 End: 04/30/13 Due: 04/30/14

Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients

Phase: N/A Priority: Normal
NCT ID: NCT03018808 Org: User:
Start: 06/03/19 End: 10/04/21 Due: 10/04/22

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Phase: N/A Priority: Normal
NCT ID: NCT02836496 Org: User:
Start: 03/07/17 End: 08/08/19 Due: 08/08/20

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00289757 Org: User:
Start: 01/01/04 End: 03/01/13 Due: 03/01/14

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01691820 Org: User:
Start: 10/05/12 End: 04/08/17 Due: 04/08/18

The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Phase: N/A Priority: Normal
NCT ID: NCT01249365 Org: User:
Start: 01/24/11 End: 01/10/17 Due: 01/10/18

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00297856 Org: User:
Start: 03/31/06 End: 12/31/06 Due: 12/31/07

Nutrition, Physical Performance & Fitness in Indian School Children

Phase: N/A Priority: Normal
NCT ID: NCT00876018 Org: User:
Start: 07/07/08 End: 12/19/08 Due: 12/19/09

A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT06640049 Org: User:
Start: 10/17/24 End: 04/15/31 Due: 04/15/32